Agglutination
Agglutination - Related Videos
07:06
Particle Agglutination Method for Poliovirus Identification
0 Views •
2011
A recently developed novel particle agglutination (PA) assay utilizing virus receptor molecule allowed a rapid and easy identification of poliovirus (PV). In this article, we will show the procedure for the PA assay for PV identification.
09:11
Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
0 Views •
Cited by 32 •
2014
Latex agglutination testing is a simple, rapid and inexpensive method for serotyping Streptococcus pneumoniae, and has also been widely applied in diagnostic microbiology. This manuscript describes the in-house production of latex agglutination reagents, quality control procedures and the application of this technique to pneumococcal serotyping.
02:45
Blood Transfusion and Agglutination
0 Views •
2021
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient. History The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
05:59
Determining the Reactivity and Titre of Serum using a Haemagglutination Assay
0 Views •
Cited by 3 •
2010
Haemagglutination is a form of agglutination where antibodies bind to red blood cells. Red blood cells are both readily available and the results are readily observable using the naked eye. This video demonstrates the steps involved in a haemagglutination assay, interpreting the results and determining the titre.
11:31
Generation of Recombinant Influenza Virus from Plasmid DNA
0 Views •
Cited by 129 •
2010
Rescue of influenza A viruses from plasmid DNA is a basic and essential experimental technique that allows influenza researchers to generate recombinant viruses to study multiple aspects in the biology of influenza virus, and to be used as potential vectors or vaccines.
FAQs
Repeated antigens provide multiple attachment sites for antibodies on neighboring cells or particles. One antibody-mediated interaction can therefore connect adjacent targets, while additional interactions extend the network into a larger lattice. This organization converts individual antigen recognition events into visible clumping, allowing the binding pattern to be assessed at the scale of the entire sample.
The extent of clumping depends partly on the concentrations of both antigen and antibody. These concentrations determine how frequently binding interactions can link neighboring targets and build aggregates. Because the visible reaction reflects this balance, interpreting an agglutination result requires attention to the relative amounts present rather than viewing clumping as independent of sample composition.
Reaction conditions affect the binding interactions that connect antigens, antibodies, cells, or particles. Changes in those conditions can alter how extensively neighboring targets become linked and, consequently, how much clumping is visible. For biology and diagnostic work, controlling or considering these conditions helps distinguish a meaningful binding pattern from a weak or poorly developed reaction.
Antigen-antibody recognition occurs at molecular surfaces, but cross-linking produces aggregates large enough to observe. The resulting clumping provides a visible readout of whether compatible binding interactions occurred among suspended targets. This makes agglutination useful when researchers need a direct, interpretable indication of immune recognition rather than relying only on invisible molecular interactions.
Blood-group identification uses predictable binding patterns to distinguish how a sample reacts with relevant binding components. When compatible surface antigens and antibodies interact, the resulting clumping supplies an observable reaction pattern for comparison. This application shows how agglutination can translate differences in cell-surface markers into a practical biological or clinical classification.
Agglutination assays can support the detection of antibodies or microbial antigens by producing a visible reaction when the relevant binding partners interact. In clinical and biological testing, that pattern helps investigators assess immune recognition and can contribute to infection diagnosis. The approach is especially valuable when a rapid, visually interpretable assay is needed.
Agglutination provides a relatively direct visual outcome: molecular binding is expressed as the formation of larger aggregates. That clear signal can be incorporated into rapid assays designed to detect antibodies or microbial antigens. Its value in assay development comes from linking specific binding patterns with an observable result that researchers can interpret in biological or diagnostic settings.